Emma Catherine Fink, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thalidomide | 5 | 2019 | 890 | 1.130 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2018 | 1352 | 0.640 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2013 | 76 | 0.440 |
Why?
|
| Point Mutation | 1 | 2018 | 1623 | 0.440 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2019 | 1861 | 0.400 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 509 | 0.350 |
Why?
|
| Casein Kinase I | 2 | 2018 | 47 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4462 | 0.260 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2043 | 0.220 |
Why?
|
| Peptide Termination Factors | 1 | 2022 | 55 | 0.210 |
Why?
|
| Cyclins | 1 | 2020 | 603 | 0.150 |
Why?
|
| Duane Retraction Syndrome | 1 | 2018 | 60 | 0.150 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5181 | 0.150 |
Why?
|
| Purines | 1 | 2020 | 594 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7880 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13695 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2020 | 1012 | 0.130 |
Why?
|
| Melanoma | 1 | 2013 | 5510 | 0.120 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 217 | 0.120 |
Why?
|
| Casein Kinase Ialpha | 1 | 2014 | 27 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1511 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 5686 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2020 | 1338 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2916 | 0.100 |
Why?
|
| SUMO-1 Protein | 1 | 2010 | 35 | 0.090 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2010 | 65 | 0.090 |
Why?
|
| Sirtuin 2 | 1 | 2010 | 97 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2072 | 0.080 |
Why?
|
| Pyridines | 1 | 2020 | 2825 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2014 | 1538 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2010 | 502 | 0.070 |
Why?
|
| Substrate Specificity | 2 | 2019 | 1801 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2018 | 634 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
| Cell Death | 2 | 2022 | 1706 | 0.060 |
Why?
|
| Species Specificity | 2 | 2018 | 2478 | 0.050 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 720 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.050 |
Why?
|
| Protein Binding | 3 | 2020 | 9386 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 1888 | 0.050 |
Why?
|
| Animals | 5 | 2022 | 168757 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.040 |
Why?
|
| Mice | 4 | 2022 | 81183 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 13815 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2018 | 29 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12208 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 3523 | 0.040 |
Why?
|
| Teratogens | 1 | 2018 | 112 | 0.040 |
Why?
|
| Chromatin | 1 | 2010 | 2934 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4204 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 671 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2018 | 478 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5853 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2015 | 743 | 0.030 |
Why?
|
| K562 Cells | 1 | 2015 | 634 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 1416 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16689 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1294 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2015 | 2256 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5456 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 3386 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18111 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 464 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 2010 | 280 | 0.020 |
Why?
|
| Humans | 7 | 2020 | 744343 | 0.020 |
Why?
|
| Male | 2 | 2018 | 350118 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1832 | 0.020 |
Why?
|
| Female | 2 | 2018 | 380194 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 913 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1580 | 0.020 |
Why?
|
| Telomere | 1 | 2010 | 910 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9648 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4584 | 0.010 |
Why?
|
| Cell Line | 1 | 2015 | 15997 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2752 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3462 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12072 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|